Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma

Hsien Tzung Liao, Chih Hung Chien, Chung Hsiung Chen, Hon Pin Wang, De Feng Huang

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

原文英語
頁(從 - 到)1008-1010
頁數3
期刊Clinical Rheumatology
26
發行號6
DOIs
出版狀態已發佈 - 六月 2007

指紋

Labyrinth Diseases
Large Cell Carcinoma
Polyarteritis Nodosa
Lung
Hearing Loss
Neoplasms
Immunosuppressive Agents
Vasculitis
Autoimmune Diseases
Lung Neoplasms
Livedo Reticularis
External Ear
Drug Therapy
Middle Ear
Cyclophosphamide
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

引用此文

Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma. / Liao, Hsien Tzung; Chien, Chih Hung; Chen, Chung Hsiung; Wang, Hon Pin; Huang, De Feng.

於: Clinical Rheumatology, 卷 26, 編號 6, 06.2007, p. 1008-1010.

研究成果: 雜誌貢獻文章

Liao, Hsien Tzung ; Chien, Chih Hung ; Chen, Chung Hsiung ; Wang, Hon Pin ; Huang, De Feng. / Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma. 於: Clinical Rheumatology. 2007 ; 卷 26, 編號 6. 頁 1008-1010.
@article{fc1fe1992d9b4a7eaa398714caabadc6,
title = "Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma",
abstract = "Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.",
keywords = "Autoimmune inner ear disease (AIED), Livedo reticularis, Malignancy, Mononeuritis multiplex, Vasculitis",
author = "Liao, {Hsien Tzung} and Chien, {Chih Hung} and Chen, {Chung Hsiung} and Wang, {Hon Pin} and Huang, {De Feng}",
year = "2007",
month = "6",
doi = "10.1007/s10067-006-0250-1",
language = "English",
volume = "26",
pages = "1008--1010",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "6",

}

TY - JOUR

T1 - Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma

AU - Liao, Hsien Tzung

AU - Chien, Chih Hung

AU - Chen, Chung Hsiung

AU - Wang, Hon Pin

AU - Huang, De Feng

PY - 2007/6

Y1 - 2007/6

N2 - Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

AB - Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

KW - Autoimmune inner ear disease (AIED)

KW - Livedo reticularis

KW - Malignancy

KW - Mononeuritis multiplex

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=34250703839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250703839&partnerID=8YFLogxK

U2 - 10.1007/s10067-006-0250-1

DO - 10.1007/s10067-006-0250-1

M3 - Article

C2 - 16552463

AN - SCOPUS:34250703839

VL - 26

SP - 1008

EP - 1010

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 6

ER -